BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 15973722)

  • 21. Lack of association between the ITPA 94C>A polymorphism and adverse effects from azathioprine.
    Gearry RB; Roberts RL; Barclay ML; Kennedy MA
    Pharmacogenetics; 2004 Nov; 14(11):779-81. PubMed ID: 15564886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thiopurine S-methyltransferase polymorphisms and the relationship between the mutant alleles and the adverse effects in systemic lupus erythematosus patients taking azathioprine.
    Jun JB; Cho DY; Kang C; Bae SC
    Clin Exp Rheumatol; 2005; 23(6):873-6. PubMed ID: 16396707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influences of thiopurine methyltransferase genotype and activity on thiopurine-induced leukopenia in Korean patients with inflammatory bowel disease: a retrospective cohort study.
    Kim JH; Cheon JH; Hong SS; Eun CS; Byeon JS; Hong SY; Kim BY; Kwon SH; Kim SW; Han DS; Yang SK; Kim WH
    J Clin Gastroenterol; 2010; 44(10):e242-8. PubMed ID: 20308917
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Yang J; Wang P; Qin Z; Jia M; Zhang C; Tian X; Zheng Y; Zhang A; Zhang X; Liu S
    Genet Test Mol Biomarkers; 2019 Oct; 23(10):751-757. PubMed ID: 31556692
    [No Abstract]   [Full Text] [Related]  

  • 25. ITPA Activity in Adults and Children Treated With or Without Azathioprine: Relationship Between TPMT Activity, Thiopurine Metabolites, and Co-medications.
    Citterio-Quentin A; Moulsma M; Gustin MP; Boulieu R
    Ther Drug Monit; 2017 Oct; 39(5):483-491. PubMed ID: 28650902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NUDT15 variant is the most common variant associated with thiopurine-induced early leukopenia and alopecia in Korean pediatric patients with Crohn's disease.
    Lee YJ; Hwang EH; Park JH; Shin JH; Kang B; Kim SY
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):475-8. PubMed ID: 26735160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism.
    Schwab M; Schäffeler E; Marx C; Fischer C; Lang T; Behrens C; Gregor M; Eichelbaum M; Zanger UM; Kaskas BA
    Pharmacogenetics; 2002 Aug; 12(6):429-36. PubMed ID: 12172211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Simple Method for TPMT and ITPA Genotyping Using Multiplex HRMA for Patients Treated with Thiopurine Drugs.
    Skrzypczak-Zielinska M; Borun P; Bartkowiak-Kaczmarek A; Zakerska-Banaszak O; Walczak M; Dobrowolska A; Kurzawski M; Waszak M; Lipinski D; Plawski A; Slomski R
    Mol Diagn Ther; 2016 Oct; 20(5):493-9. PubMed ID: 27307154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of thiopurine methyltransferase status with azathioprine side effects in Chinese patients with systemic lupus erythematosus.
    Chen D; Lian F; Yuan S; Wang Y; Zhan Z; Ye Y; Qiu Q; Xu H; Liang L; Yang X
    Clin Rheumatol; 2014 Apr; 33(4):499-503. PubMed ID: 24322830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thiopurine S-methyltransferase polymorphism in Iranian kidney transplant recipients.
    Aghdaie MH; Azarpira N; Geramizadeh B; Sagheb M; Darai M; Rahsaz M; Malekhoseini SA
    Exp Clin Transplant; 2011 Aug; 9(4):241-6. PubMed ID: 21819368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No induction of thiopurine methyltransferase during thiopurine treatment in inflammatory bowel disease.
    Lindqvist M; Hindorf U; Almer S; Söderkvist P; Ström M; Hjortswang H; Peterson C
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1033-7. PubMed ID: 17065060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of the heterozygous TPMT*1/*3C genotype on azathioprine-induced myelosuppression in kidney transplant recipients in Thailand.
    Vannaprasaht S; Angsuthum S; Avihingsanon Y; Sirivongs D; Pongskul C; Makarawate P; Praditpornsilpa K; Tassaneeyakul W; Tassaneeyakul W
    Clin Ther; 2009 Jul; 31(7):1524-33. PubMed ID: 19695401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thiopurine methyltransferase genotype and the toxicity of azathioprine in Japanese.
    Ishioka S; Hiyama K; Sato H; Yamanishi Y; McLeod HL; Kumagai K; Maeda H; Yamakido M
    Intern Med; 1999 Dec; 38(12):944-7. PubMed ID: 10628931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of
    Wang HH; He Y; Wang HX; Liao CL; Peng Y; Tao LJ; Zhang W; Yang HX
    World J Gastroenterol; 2018 Feb; 24(8):941-948. PubMed ID: 29491687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of thiopurine methyltransferase (TPMT) polymorphisms cannot predict myelosuppression in systemic lupus erythematosus patients taking azathioprine.
    Naughton MA; Battaglia E; O'Brien S; Walport MJ; Botto M
    Rheumatology (Oxford); 1999 Jul; 38(7):640-4. PubMed ID: 10461478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel disease.
    Hindorf U; Lindqvist M; Peterson C; Söderkvist P; Ström M; Hjortswang H; Pousette A; Almer S
    Gut; 2006 Oct; 55(10):1423-31. PubMed ID: 16543290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of Genetic Polymorphisms of Genes Implicated in Thiopurine Drugs Metabolism.
    Chadli Z; Kerkeni E; Hannachi I; Chouchene S; Ben Fredj N; Boughattas NA; Aouam K; Chaabane A
    Ther Drug Monit; 2018 Oct; 40(5):655-659. PubMed ID: 30086084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription.
    Fargher EA; Tricker K; Newman W; Elliott R; Roberts SA; Shaffer JL; Bruce I; Payne K
    J Clin Pharm Ther; 2007 Apr; 32(2):187-95. PubMed ID: 17381669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thiopurine S-methyltransferase gene polymorphism is predictive of azathioprine-induced myelosuppression in heart transplant recipients.
    Sebbag L; Boucher P; Davelu P; Boissonnat P; Champsaur G; Ninet J; Dureau G; Obadia JF; Vallon JJ; Delaye J
    Transplantation; 2000 Apr; 69(7):1524-7. PubMed ID: 10798786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Azathioprine dose tailoring based on pharmacogenetic information: Insights of clinical implementation.
    Díaz-Villamarín X; Fernández-Varón E; Rojas Romero MC; Callejas-Rubio JL; Cabeza-Barrera J; Rodríguez-Nogales A; Gálvez J; Morón R
    Biomed Pharmacother; 2023 Dec; 168():115706. PubMed ID: 37857254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.